Abstract
Sjögren’s syndrome (SS) is characterised as keratoconjunctivitis sicca (dry eyes), xerostomia (dry mouth) commonly associated with salivary gland enlargement, and is referred to as Primary Sjögren’s syndrome. It is known as Secondary Sjögren’s syndrome when it occurs in patients, with connective tissue disease, such as rheumatoid arthritis, systemic lupus erythematosus, polyarthritis nodosa, polymyositis, and systemic sclerosis. SS has also been associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation, human immunodeficiency syndrome (AIDS), hepatitis C infection (HCV), chronic biliary cirrhosis, neoplastic and myeloplastic syndromes, fibromyalgia, and chronic fatigue syndrome.
Similar content being viewed by others
Data availability
Enquiries about data availability should be directed to the authors.
References
Agman-Levin N, Kivity S, Tzioufas AG et al (2012) Low levels vitamin D are associated with neuropathy and lymphoma among patients with Sjögren’s syndrome. J Autoimmun 39:234–239
Albrich K (1928) Filiform keratitis due to insufficient secretion of lacrimal glands. 3 cases. Arch Ophthal 121:402–410
Ambrosi A, Salomonsson S, Eliasson H et al (2012) Development of heart block in children of SSA/SSB—autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern. Ann Rheum Dis 71:334–340
Baldini C, Luciano N, Tarantini G, Pascale R, Sernissi F, Mosca M, Caramella D, Bombardieri S (2015) Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren’s syndrome. Arthritis Res Ther 17(1):146–154
Beck JS, Anderson JR, Bloch KJ et al (1965) Antinuclear and precipitating autoantibodies in Sjögren’s syndrome. Ann Rheum Dis 24:16–22
Betsch A (1928) Die chronische Keratitis filiformis als Folge mangelnder Tränensekretion. Klin Mbl Augenheilk 80:618–623
Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ (1965) Sjögren’s syndrome. A clinical, pathological, and serological study of sixty-two cases. Medicine (baltimore) 44:187–231
Bowman SJ, Booth DA, Platts RG et al (2003) Validation of the sicca symptoms inventory for clinical studies of Sjögren’s syndrome. J Rheumatol 30(6):1259–1266
Bowman SJ, Booth DA, Platts RG (2004) Measurement of fatigue and discomfort in primary Sjögren’s syndrome using a new questionnaire tool. Rheumatology (oxford) 43(6):758–764
Buchanan WW (1997) Sjögren’s syndrome: the persisting conundrum. J Rheumatol 24:1667–1669
Cantaert T, Baeten D, Tak PT, van Baarsen LGM (2010) Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance. Arthritis Res Ther 12:219
Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjögren’s syndrome. J Clin Pathol 21:656–660
Ciccia F, Accardo-Palumbo A, Alessandro R, Alessandri C, Priori R, Guggino G, Raimondo S, Carubbi F, Valesini G, Giacomelli R, Rizzo A, Triolo G (2015) Interleukin-36α axis is modulated in patients with primary Sjögren’s syndrome. Clin Exp Immunol 181(2):230–238
Daniels TE, Aufdemorte TB, Greenspan JS (1987) Histopathology of Sjögren’s syndrome. In: Talal N, Moutsopoulos HM, Kassan SS (eds) Sjögren’s syndrome: clinical and immunological aspects. Springer-Verlag, Berlin, pp 266–286
Fauchais Al, Martel C, Gondran G et al (2010) Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev 9:595–599
Ferro F, Vagelli R, Bruni C et al (2016) One year in review 2016: Sjögren’s syndrome. Clin Exp Rheumatol 34:161–171
Fuchs A (1919) Ein Fall von Fehlen der Tränen- und Mundspeichel-Sekretion. A Augenh 42:253–254
García-Carrasco M, Ramos M, Cervera R et al (1997) Hepatitis C virus infection in ‘primary’ Sjögren’s syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis 56:173–175
Gougerot H (1926) Insuffisance progressive et atrophie dess glandes salivaires et muqueuses de la bouche, des conjenctives (et parfois des muqueuses nasale, laryngee, vulvainre) secheresse de la bouche, des conjunctives, et. Bull Med (paris) 40:360–368
Hadden WB (1888) On “dry mouth”, or suppression of the salivary and buccal secretions. Trans Clin Soc London 21:176–179
Hickish T, Cunningham D, Colston K et al (1993) The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br Cancer 68:668–672
Houwer AWM (1927) Keratitis fermentosa and chronic arthritis. Trans Ophthal Soc, UK 47:88–96
Isakowitz J (1928) Die Endokrine Periarthritis (Uber) und Keratitis filiformis. Klin Monatsblätter Augenheilkunde 81:85–86
Kay RA, Hay EM, Dyer PA et al (1991) An abnormal T cell repertoire in hypergammaglobulinaemic primary Sjögren’s syndrome. Clin Exp Immunol 85:262–264
Kincaid MC (1987) The eye in Sjögren’s syndrome. In: Talal N, Moutsopoulos HM, Kassam SS (eds) Sjögren’s syndrome: clinical and Immunological Aspects. Springer-Verlag, Berlin, pp 25–34
Leber T (1982) Ueber die Entstehung der Netzhautablösung. Ber Versamml Ophthal Ges Stuttg 14:164–166
Luppi F, Sebastiani M, Silva M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A (2020) Interstitial lung disease in Sjögren’s syndrome: a clinical review. Clin Exp Rheumatol 38(Suppl 126):291–300
Mariette X, Seror R, Quartuccio L, Baron G, Salvin S, Fabris M, Desmoulins F, Nocturne G, Ravaud P, De Vita S (2015) Efficacy and safety of belimumab in primary Sjögren’s syndrome: results of the BELISS open-label phase II study. Ann Rheum Dis 74(3):526–531
Martin T, Weber JC, Levalloi H et al (2000) Salivary gland lymphomas in patients with Sjögren’s syndrome may frequently develop from rheumatoid factor B cells. Arthritis Rheum 43:908–916
Maslinska M, Przygodzka M, Kwiatkowska B, Sikorska-Siudek K (2015) Sjögren’s syndrome: still not fully understood disease. Rheumatol Int 35:233–241
Morgan WS, Castleman B (1953) A clinicopathologic study of “Mikulicz’s disease.” Amer J Path 29:471–503
Moutsopoulos HM (1994) Sjögren’s syndrome: autoimmune epithelitis. Clin Immunol Immunopath 72:162–165
Moutsopoulos HM, Webber BL, Vlagopoulos TP et al (1979) Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med 66:733–736
Nezos A, Gravani F, Tassidou A, Kapsogeorgou EK, Voulgarelis M, Koutsilieris M, Crow MK, Mavragani CP (2015) Type I and II interferon signatures in Sjogren’s syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren’s related lymphomagenesis. J Autoimmun 63:47–58
Osler W (1892) Principles and practice of medicine. D. Appleton and Co., New York, p 328. (Reprinted by the Classics of Medicine Library, Division of Gryphon Editions, Birmingham, Alabama USA, 1978)
Park AL, Buchanan WW (1998) Sjögren”s syndrome: history, clinical and pathological features. Immunopharmacology 6:271–287
Park WM, Mason DK (1966) Hydrostatic sialography. Radiology 86:116–122
Parrago G, Rain GD, Bronchierion C, Rocher F (1987) Scintigraphy of the salivary glands in Sjögren’s syndrome. J Clin Pathol 40:1463–1467
Pflugfelder SC, Tseng SC, Yoshino K et al (1997) Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose Bengal staining in patients with ocular irritation. Opthalmol 104:223–235
Price EJ, Rauz S, Tappuni AR, Sutcliffe N, Hackett KL, Barone F, Granata G, Ng W-F, Fisher BA, Bombardieri M, Astorri E, Empson B, Larkin G, Crampton B, Bowman SJ, on behalf of the British Society for Rheumatology Standards, Guideline and Audit Working Group (2017) The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome. Rheumatology 56(10):e24–e48
Quartuccio L, Isola M, Baldini C et al (2015) Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren’s syndrome: results of a large multicentre study. Scand J Rheumatol 44:36–41
Ramon-Casals M, Brito-Zeron P, Kostov B et al (2015) Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases. Autoimmun Rev 14:670–679
Reveille JD, MacLeod MJ, Whittington K, Arnett FC (1991) Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DAB1 chain genes promote the Ro(SSA)/La(SSB) autoantibody responses. J Immunol 146:3871–3875
Salliot C, Gottenberg JE, Bengoufa D et al (2007) Anticentromere antibodies identify patients with Sjögren’s syndrome and autoimmune overlap syndrome. J Rheumatol 34:2253–2258
Sankar V, Brennan MT, Kok MR et al (2004) Etanercept in Sjögren’s syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis & Rheumatology 50(7):2240–2245
Schaffer AJ, Jacobsen AW (1927) Mikulicz’s syndrome: a report of ten cases. Am J Dis Child 34:327–346
Schirmer OWA (1903) Studien zur Physiologie und Pathologie der Tränenabfuhr. Albrecht Von Graefess Archiv Kil Exp Ophthalmol 56:197–291
Schöninger L (1924) Ueber Keratitis filiformis bei Hypofunktion der Tränendrüsen. Klin Mbl Augenheilk 73:208–210
Schur PH (1995) Review: genetics of systemic lupus erythematosus. Lupus 4:425–437
Scofield RH, Fayyaz A, Kurien B, Koelsch KA (2018) Prognostic value of Sjögren’s syndrome autoantibodies. J Lab Prec Med 3:92–103
Seror L, Ravaud P, Bowman SJ et al (2010a) Validation of EULAR Sjögren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren’s syndrome. Ann Rheum Dis 69(6):1103–1109
Seror R, Mariette X, Bowman S et al (2010b) Accurate detection of changes in disease activity in primary Sjögren’s syndrome by the European league against rheumatism Sjögren’s syndrome disease activity index. Arthritis Care & Research (hoboken) 62(4):551–558
Seror R, Theander E, Brun JG et al (2013) Validation of EULAR primary Sjögren’s syndrome disease activity and patient indexes. Arthritis Rheum 64(10):S1078
Shiboski CH, Shiboski SC, Seror R et al (2016) American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome. A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheum. 2017 Jan;69(1):35–45 https://doi.org/10.1002/art.39859. Epub 2016 Oct 26. PMID: 27785888; PMCID: PMC5650478
Sjögren H (1933) Zur Kenntnis der Keratoconjunctivitis sicca (Keratitis filiformis bei Hypofunktion der Tränendrüsen) Acta Ophthal (Klh) 11:1–151. (Translated by J.B. Hamilton, Tasmania, Australia. A New Conception of Keratoconjunctivitis Sicca (Keratitis Filiformis in Hypofunction of the Lacrimal Glands). Sydney Australia. Australian Medical Publishing Company, 1943)
Skopouli FN, Siouna-Fatourou NI, Ziciadis C, Moutsopoulos HM (1989) Evaluation of unstimulated whole saliva flow rate and stimulated parotid flow as confirmatory tests for xerostomia. Clin Exper Rheumatol 7:127–129
Strand V, Talal N (1980) Advances in the diagnosis and concept of Sjögren’s syndrome (autoimmune exocrinopathy). Bull Rheum Dis 30:1046–1052
Talal N (ed) (1989). Academic Press, London
Talal N (1994) Historical overview of Sjögren’s syndrome. Clin Exper Rheumatol 12(Suppl 11):3–4
Talal N, Bunim JJ (1964) The development of malignant lymphoma in the course of Sjögren’s syndrome. Amer J Med 36:529–540
Talal N, Moutsopoulos HM, Kassam SS (eds) (1987). Springer-Verlag, Heidelberg
Tincani A, Andreoli L, Cavazzana I et al (2013) Novel aspects of Sjögren’s syndrome in 2012. BMC Med 11:93
Tung CH, Chen YC, Chen YC (2022) Association between anti-hepatitis C viral intervention therapy and risk of Sjögren’s syndrome: a national retrospective analysis. J Clin Med 11(15):4259–4270
Tzioufas AG, Moutsopoulos HM, Talal N (1987) Lymphoid malignancy and monoclonal proteins. In: Talal N, Mautsopoulos HM, Kassam SS (eds) Sjögren’s syndrome: clinical and immunological aspects. Springer-Verlag, Berlin, pp 129–136
Vitali C, Bombardieri S, Moutsopoulos HM et al (1993) Preliminary criteria for the classification of Sjögren’s syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 36:340–347
Vitali C, Moutsopoulos HM, Bombardieri S et al (1994) The European Community study Group on diagnostic criteria for Sjögren‘s syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren’s syndrome. Ann Rheum Dis 53:637–647
von Mikulicz-Radecki J (1892) Ueber eine eigenartige symmetrische Erkrankung des Tränen – und Mundspeicheldrüsen. In: Beitrage zur Chirurgie. Festschrift Gewid. Stuttgart. T Bilroth, pp 610–630. (English translation by J.B. Hamilton: Concerning a peculiar symmetrical disease of the lacrimal and salivary glands. Med Classics 2:165–186 1937)
Whaley K, Chisholm DM, Downie WW et al (1968) Lymphocytic sialedenitis in the buccal mucosa in Sjögren’s disease, rheumatoid arthritis and other arthritides; a clinical and laboratory study. Acta Rheum Scand 14:298–308
Whaley K, Blair S, Low PS et al (1972) Sialographic abnormalities in Sjögren’s syndrome, rheumatoid arthritis and other arthritides and connective tissue disease: a clinical and radiological investigation using hydrostatic sialography. Clin Radiol 23:474–482
Whaley K, Webb J, McAvory BA (1973a) Sjögren’s syndrome II. Clinical associations and immunological phenomena. Quart J Med 42:513–548
Whaley K, Williamson J, Chisholm DM et al (1973b) Sjögren’s syndrome I. Sicca components. Quart J Med 42:279–304
Williamson J, Alison M (1967) Effect of temperature and humidity in Schirmer’s tear test. Br J Opthal 51:596–598
Funding
The authors have not disclosed any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have not disclosed any competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Balint, G., Watson Buchanan, W., Kean, C.A. et al. Sjögren’s syndrome. Inflammopharmacol 32, 37–43 (2024). https://doi.org/10.1007/s10787-023-01222-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-023-01222-z